TGFB1 and coronary artery disorder: It is possible that the rs1800469 polymorphism alters promoter affinity for the transcription factors and inhibits TGFβ expression, thus activating proinflammatory cytokines (tumour necrosis factor α and interleukin 1) that contribute to the progression of CAD [58].